We recently compiled a list of the 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2024 on Wednesday, January 29, 2025 beginning at 8:00 a.m. ET and lasting ...

Danaher Corporation (NYSE: DHR) shares went into a tailspin when the Abcam deal came into question, but the dip turned out to ...

Check the time stamp on this data. Updated AI-Generated Signals for Danaher Corporation (DHR) available here: DHR.

Danaher Corporation DHR has failed to impress investors with its recent operational performance due to softness in the Life Sciences segment. Also, increasing expenses are likely to impede the ...

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...

I consider Danaher Corporation (NYSE:DHR) a good investment opportunity. The company has kept its net earnings margin relatively stable. Since 2017, this margin has been above 15%. In addition ...

Bioconjugation Market Bioconjugation Market Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Bioconjugation Market by Product ...

Danaher Corporation (DHR), valued at a market cap of $164.6 billion, is a leading global life sciences and diagnostics innovator based in Washington, D.C. It designs, manufactures, and markets ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks. Jim Cramer, the host of Mad Money, recently shared some investment guidelines ...